Tergooi Ziekenhuis

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Chronic lymphocytic leukaemia1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Type 1 diabetes1 trial

Phase

• Phase 32 trials

Status

• Completed3 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• German CLL Study Group1 trial
• UMC Utrecht1 trial

Closed trials

• Completed

  Dual Hormone Closed Loop in Type 1 Diabetes

  NCT05669547· UMC Utrecht· Source

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  Standard Chemoimmunotherapy (FCR/BR) Versus Rituximab + Venetoclax (RVe) Versus Obinutuzumab (GA101) + Venetoclax (GVe) Versus Obinutuzumab + Ibrutinib + Venetoclax (GIVe) in Fit Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without Del(17p) or TP53 Mutation

  NCT02950051· Phase 3· German CLL Study Group· Source